Sargent Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sargent Investment Group's LLY Position: Q2 2026 in Review
Sargent Investment Group reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $156K and leaving 5,913 shares worth $7.09M. The position accounts for 0.85% of the portfolio, ranked #27.
Sargent Investment Group first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Sargent Investment Group held 5,913 shares of Eli Lilly worth $7.09M as of Q2 2026.
- Sargent Investment Group sold 153 Eli Lilly shares in Q2 2026, an estimated $156K.
- Eli Lilly made up 0.85% of Sargent Investment Group's portfolio in Q2 2026, its #27 holding.
- Sargent Investment Group first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.